New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.

Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

June 23, 2024

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy – Pharmaceutical Technology

An oral EQ302 formulation could offer a convenient, bioavailable therapy for patients with inflammatory and autoimmune diseases. Image: Shutterstock/ Busra Ispir. Massachusetts-based biotech Vivtex and

September 17, 2024

ViiV Healthcare and Doctors Without Borders tussle over contract terms for an HIV drug

A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to allow the relief organization to purchase an injectable HIV prevention

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.